Out For Tender

Out For Tender › Reino Unido › Equipo de laboratorio, óptico y de precisión (excepto gafas)

WBS-FTS-64245 Haematology Testing System

Órgano de contratación
Velindre University NHS Trust
País
Reino Unido
Categoría
Equipo de laboratorio, óptico y de precisión (excepto gafas)
Importe
£409k GBP
Fecha límite
Cierra en 7 días (4 Nov 2026 12:00 UTC+0)
Publicada
6 Oct 2026
Procedimiento
Open
Código CPV
38434570

Leer el anuncio oficial y licitar → La presentación de ofertas se realiza siempre en el portal del órgano de contratación, nunca aquí.

Qué solicita el órgano de contratación

The Welsh Blood Service (WBS) requires an advanced automated haematology analysis system to support blood donor assessment, blood component quality monitoring, research and innovation activities. The proposed solution will be required to provide automated full blood count (FBC) analysis, 5-part white cell differential capability and integrated reticulocyte analysis on the primary analyser. Of particular interest are systems capable of generating the data required to support emerging donor health assessment methodologies, including FlowScore calculation and reticulated haemoglobin analysis for the early detection of iron deficiency in blood donors. The requirement is includes advanced analytical capabilities that support the unique operational needs of a blood establishment. These include fluorescence platelet counting with high accuracy at low platelet concentrations, reticulated platelet measurement, low-level white cell enumeration suitable for blood component quality monitoring, and the ability to perform blood component testing without the need for separate instrumentation. Suppliers should be able to demonstrate how their platforms support routine blood component quality control programmes through dedicated blood bank functionality and provide evidence of successful implementation within blood services, blood centres or comparable blood establishments. WBS is particularly interested in solutions that are supported by robust External Quality Assessment (EQA/EQAS) programmes and can demonstrate meaningful peer group benchmarking through sufficient participant numbers using the same analyser platform and methodology. Suppliers should be able to demonstrate compliance with applicable medical device regulations, support quality and regulatory requirements through a mature quality management system and provide resilient service and maintenance arrangements that minimise downtime and ensure continuity of critical testing services.

Idioma de este anuncio: English. El título y la descripción se muestran tal como los publicó el órgano de contratación.

Source: FTS · reference ocds-h6vhtk-06ebd3 · JSON